Application 207807

Type: ANDA
Sponsor: GLENMARK PHARMS LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 5MG BASE;20MG	No	No
002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 5MG BASE;40MG	No	No
003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 10MG BASE;20MG	No	No
004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 10MG BASE;40MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2017-07-05
A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2017-07-05
A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2017-07-05
A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2017-07-05

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL		2017-07-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL		2017-07-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL		2017-07-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL		2017-07-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	AB	2017-07-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	AB	2017-07-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	AB	2017-07-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	AB	2017-07-05	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 124 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207807-004	AB	1	`5bbf6a4d5a75…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207807-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207807-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207807-003	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207807-004	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207807-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207807-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207807-003	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207807-004	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207807-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207807-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207807-003	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207807-004	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A207807-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A207807-002	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A207807-003	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A207807-004	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207807-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207807-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207807-003	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207807-004	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A207807-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A207807-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A207807-003	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A207807-004	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A207807-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A207807-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A207807-003	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A207807-004	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A207807-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A207807-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A207807-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A207807-004	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A207807-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A207807-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A207807-003	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A207807-004	AB	1	`bb7c543d1eb4…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Amlodipine and Olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Glenmark Pharmaceuticals Inc., USA	2edf43fb-0755-4ffb-bc38-75a4e2432588	2021-02-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 207807 application number: ANDA207807 ndc (product): 68462-567 ndc (product): 68462-569 ndc (product): 68462-566 ndc (product): 68462-568

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 35 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
45865-923	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	medsource pharmaceuticals	ANDA	Current
45865-935	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	medsource pharmaceuticals	ANDA	Current
45865-947	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	medsource pharmaceuticals	ANDA	Current
60505-4582	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Apotex Corp.	ANDA	Current
60505-4583	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Apotex Corp.	ANDA	Current
60505-4584	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Apotex Corp.	ANDA	Current
60505-4585	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Apotex Corp.	ANDA	Current
68462-566	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-566	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-566	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-566	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-566	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-566	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-566	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-567	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-567	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-567	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-567	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-567	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-567	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-567	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-568	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-568	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-568	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-568	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-568	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-568	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-568	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-569	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-569	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-569	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-569	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-569	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-569	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current
68462-569	Amlodipine and Olmesartan Medoxomil	Amlodipine and Olmesartan Medoxomil	Glenmark Pharmaceuticals Inc., USA	ANDA	Current